CH591431A5 - - Google Patents

Info

Publication number
CH591431A5
CH591431A5 CH1721773A CH1721773A CH591431A5 CH 591431 A5 CH591431 A5 CH 591431A5 CH 1721773 A CH1721773 A CH 1721773A CH 1721773 A CH1721773 A CH 1721773A CH 591431 A5 CH591431 A5 CH 591431A5
Authority
CH
Switzerland
Application number
CH1721773A
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of CH591431A5 publication Critical patent/CH591431A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/185Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CH1721773A 1972-12-07 1973-12-07 CH591431A5 (US06248540-20010619-C00021.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12287472A JPS5623982B2 (US06248540-20010619-C00021.png) 1972-12-07 1972-12-07

Publications (1)

Publication Number Publication Date
CH591431A5 true CH591431A5 (US06248540-20010619-C00021.png) 1977-09-15

Family

ID=14846750

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1721773A CH591431A5 (US06248540-20010619-C00021.png) 1972-12-07 1973-12-07

Country Status (12)

Country Link
US (1) US4018817A (US06248540-20010619-C00021.png)
JP (1) JPS5623982B2 (US06248540-20010619-C00021.png)
BE (1) BE808376A (US06248540-20010619-C00021.png)
CA (1) CA1018161A (US06248540-20010619-C00021.png)
CH (1) CH591431A5 (US06248540-20010619-C00021.png)
DE (1) DE2359537C2 (US06248540-20010619-C00021.png)
DK (1) DK133297C (US06248540-20010619-C00021.png)
FR (1) FR2209748B1 (US06248540-20010619-C00021.png)
GB (1) GB1392270A (US06248540-20010619-C00021.png)
HU (1) HU168454B (US06248540-20010619-C00021.png)
NL (1) NL7316834A (US06248540-20010619-C00021.png)
SE (1) SE407568B (US06248540-20010619-C00021.png)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8508588D0 (en) * 1985-04-02 1985-05-09 Akzo Nv Indene & napthalene derivatives
DE69510933T2 (de) * 1994-05-10 1999-11-11 The Wellcome Foundation Ltd., Greenford Amidderivate und ihre therapeutische anwendung
MY113062A (en) * 1994-05-10 2001-11-30 The Wellcome Foundation Ltd Amide derivatives and their therapeutic use
WO1996015099A1 (en) * 1994-11-09 1996-05-23 Novo Nordisk A/S Heterocyclic compounds, their preparation and use

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2798888A (en) * 1952-08-12 1957-07-09 Ciba Pharm Prod Inc Indene and indane compounds and their production
US3325358A (en) * 1962-06-06 1967-06-13 Merck & Co Inc Method of treating inflammation
GB1139135A (en) * 1965-10-01 1969-01-08 Kefalas As Aminoalkyl-substituted indanes and pharmaceutical compositions containing them
US3532752A (en) * 1965-12-30 1970-10-06 Merck & Co Inc 1-alkylidene-3-indenyl aliphatic amines
US3622623A (en) * 1968-08-28 1971-11-23 Merck & Co Inc 1-substituted indenyl-3-aliphatic acids and esters
SE367181B (US06248540-20010619-C00021.png) * 1969-05-14 1974-05-20 Takeda Chemical Industries Ltd
US3565943A (en) * 1969-09-17 1971-02-23 Bristol Myers Co 1-indancarboxylic acids and derivatives
US3644479A (en) * 1970-02-09 1972-02-22 Bristol Myers Co 1-indancarboxylic acids and derivatives
NO136750C (no) * 1972-06-19 1977-11-02 Takeda Chemical Industries Ltd Fremgangsm}te for fremstilling av indanderivater
US3953500A (en) * 1973-08-11 1976-04-27 Takeda Chemical Industries, Ltd. Benzalicyclic carboxylic acid derivative

Also Published As

Publication number Publication date
FR2209748A1 (US06248540-20010619-C00021.png) 1974-07-05
CA1018161A (en) 1977-09-27
DE2359537C2 (de) 1984-06-14
BE808376A (fr) 1974-06-07
HU168454B (US06248540-20010619-C00021.png) 1976-04-28
US4018817A (en) 1977-04-19
JPS4980054A (US06248540-20010619-C00021.png) 1974-08-02
AU6333473A (en) 1975-06-12
DK133297B (da) 1976-04-26
DE2359537A1 (de) 1974-06-12
SE407568B (sv) 1979-04-02
GB1392270A (en) 1975-04-30
NL7316834A (US06248540-20010619-C00021.png) 1974-06-11
DK133297C (da) 1976-09-20
FR2209748B1 (US06248540-20010619-C00021.png) 1976-05-07
JPS5623982B2 (US06248540-20010619-C00021.png) 1981-06-03

Similar Documents

Publication Publication Date Title
FR2182962A1 (US06248540-20010619-C00021.png)
JPS5755444B2 (US06248540-20010619-C00021.png)
FR2209748B1 (US06248540-20010619-C00021.png)
JPS5140137Y2 (US06248540-20010619-C00021.png)
SU431458A1 (US06248540-20010619-C00021.png)
JPS5143471Y2 (US06248540-20010619-C00021.png)
JPS5140190Y2 (US06248540-20010619-C00021.png)
JPS5228296Y2 (US06248540-20010619-C00021.png)
JPS4946639A (US06248540-20010619-C00021.png)
JPS4935020U (US06248540-20010619-C00021.png)
CH578838A5 (US06248540-20010619-C00021.png)
CH581095A5 (US06248540-20010619-C00021.png)
CH585228A5 (US06248540-20010619-C00021.png)
CH585157A5 (US06248540-20010619-C00021.png)
CH584416A5 (US06248540-20010619-C00021.png)
CH583094A5 (US06248540-20010619-C00021.png)
BG19428A1 (US06248540-20010619-C00021.png)
CH582640A5 (US06248540-20010619-C00021.png)
CH582395A5 (US06248540-20010619-C00021.png)
CH582166A5 (US06248540-20010619-C00021.png)
CH580570A5 (US06248540-20010619-C00021.png)
CH581224A5 (US06248540-20010619-C00021.png)
CH555674A4 (US06248540-20010619-C00021.png)
CH590827A5 (US06248540-20010619-C00021.png)
CH585306B5 (US06248540-20010619-C00021.png)

Legal Events

Date Code Title Description
PL Patent ceased